HighVolumeHDF – most advanced and still cost-efficient

It is not only the possible reduction of overall treatment cost which makes HighVolumeHDF with the 5008 CorDiax attractive, but it is also its eco-friendliness and the associated financial savings due to an effective and sustainable use of resources.

Best use of resources with the CorDiax product line

The innovative and highly automated features of the CorDiax product line support nursing staff by optimizing daily workflows and ensuring high and consistent levels of patient safety. The result is an easy integration of HighVolumeHDF in the daily routine.

The preparation of sterile, non-pyrogenic substitution fluid for HighVolumeHDF is based on a double-stage filtration process.

  • No extra costs for an additional single-use filter.
  • No need for ready-made rinse solutions or waste bag for priming or reinfusion.

The AutoFlow feature automatically adapts the dialysate flow to the blood flow. This generates substantial savings in water, waste water, concentrates and energy, and results in considerable cost reductions.

HighVolumeHDF – lower overall treatment costs

The main drivers for dialysis-related treatment costs are, in addition to direct procedure costs, hospitalisation, and erythropoietin (EPO) and phosphate binder usage. In an economically-tight environment every opportunity to reduce the overall treatment cost should be examined.

  • A high hospitalisation rate does not only impacting the patients' quality of life but is the most expensive form of medical care in every healthcare system. HighVolumeHDF has the potential to significantly reduce hospitalisation rates and hypotensive episodes.3
  • The amount of EPO1 and phosphate binders administered to dialysis patients has been shown to be reduced with the application of HDF. 1-2

Thus, higher quality of care can be provided at a lower medication burden and medication cost.

1 Ok E., et al., Nephrol Dial Transplant (2013); 28: 192-202.
2 Pedrini, LA. et al., Nephrol Dial Transplant (2011); 26: 2617-2624.
3 Maduell F. et al., J Am Soc Nephrol (2013); 24: 487-497.